P. Vertongen

665 total citations
23 papers, 527 citations indexed

About

P. Vertongen is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, P. Vertongen has authored 23 papers receiving a total of 527 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Cellular and Molecular Neuroscience, 15 papers in Molecular Biology and 8 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in P. Vertongen's work include Neuropeptides and Animal Physiology (18 papers), Receptor Mechanisms and Signaling (13 papers) and Chemical Synthesis and Analysis (5 papers). P. Vertongen is often cited by papers focused on Neuropeptides and Animal Physiology (18 papers), Receptor Mechanisms and Signaling (13 papers) and Chemical Synthesis and Analysis (5 papers). P. Vertongen collaborates with scholars based in Belgium, France and Spain. P. Vertongen's co-authors include Patrick Robberecht, Michal Svoboda, M. Tastenoy, Magalì Waelbroeck, Jason Perret, Jan Trouerbach, Philippe De Neef, Luc Jordaens, Yves Vandekerckhove and Eric DeRycke and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, Gut and Endocrinology.

In The Last Decade

P. Vertongen

21 papers receiving 506 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
P. Vertongen Belgium 10 239 232 143 136 118 23 527
S Ciani Italy 6 61 0.3× 127 0.5× 190 1.3× 321 2.4× 115 1.0× 9 431
Chiara Caliumi Italy 11 69 0.3× 111 0.5× 90 0.6× 100 0.7× 30 0.3× 27 320
O Kida Japan 6 287 1.2× 247 1.1× 53 0.4× 94 0.7× 28 0.2× 14 398
Masateru Nishiki Japan 12 75 0.3× 69 0.3× 56 0.4× 192 1.4× 13 0.1× 26 367
Hiroyuki Konya Japan 10 72 0.3× 102 0.4× 75 0.5× 109 0.8× 13 0.1× 22 285
Jean-Marie Gasc France 8 22 0.1× 302 1.3× 70 0.5× 166 1.2× 30 0.3× 12 533
Edit Gláz Hungary 15 48 0.2× 142 0.6× 206 1.4× 447 3.3× 22 0.2× 56 646
Kazuwa Nakao Japan 8 37 0.2× 149 0.6× 45 0.3× 57 0.4× 29 0.2× 13 372
P Chowdhury United States 10 50 0.2× 154 0.7× 97 0.7× 45 0.3× 46 0.4× 19 349
Kazuyoshi Tadokoro Japan 11 173 0.7× 234 1.0× 48 0.3× 98 0.7× 33 0.3× 15 421

Countries citing papers authored by P. Vertongen

Since Specialization
Citations

This map shows the geographic impact of P. Vertongen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P. Vertongen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P. Vertongen more than expected).

Fields of papers citing papers by P. Vertongen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P. Vertongen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P. Vertongen. The network helps show where P. Vertongen may publish in the future.

Co-authorship network of co-authors of P. Vertongen

This figure shows the co-authorship network connecting the top 25 collaborators of P. Vertongen. A scholar is included among the top collaborators of P. Vertongen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P. Vertongen. P. Vertongen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Prévost, Martine, P. Vertongen, & Magalì Waelbroeck. (2012). Identification of Key Residues for the Binding of Glucagon to the N-Terminal Domain of its Receptor: An Alanine Scan and Modeling Study. Hormone and Metabolic Research. 44(11). 804–809. 5 indexed citations
2.
Langer, Ingrid, P. Vertongen, Jason Perret, Magalì Waelbroeck, & Patrick Robberecht. (2003). Lysine 195 and aspartate 196 in the first extracellular loop of the VPAC1 receptor are essential for high affinity binding of agonists but not of antagonists. Neuropharmacology. 44(1). 125–131. 8 indexed citations
3.
Perret, Jason, P. Vertongen, Rosa M. Solano, et al.. (2002). Two tyrosine residues in the first transmembrane helix of the human vasoactive intestinal peptide receptors play a role in supporting the active conformation. British Journal of Pharmacology. 136(7). 1042–1048. 6 indexed citations
4.
Langer, Ingrid, et al.. (2002). A small sequence in the third intracellular loop of the VPAC1 receptor is responsible for its efficient coupling to the calcium effector. Biochemical Society Transactions. 30(4). 447–450. 4 indexed citations
5.
Waelbroeck, Magalì, et al.. (2002). Identification of secretin, vasoactive intestinal peptide and glucagon binding sites: from chimaeric receptors to point mutations. Biochemical Society Transactions. 30(4). 437–441. 6 indexed citations
6.
Langer, Ingrid, Jason Perret, P. Vertongen, Magalì Waelbroeck, & Patrick Robberecht. (2001). Vasoactive intestinal peptide (VIP) stimulates [Ca2+]iand cyclic AMPin CHO cells expressing Gα16. Cell Calcium. 30(4). 229–234. 22 indexed citations
7.
Vertongen, P., Rosa M. Solano, Jason Perret, et al.. (2001). Mutational analysis of the human vasoactive intestinal peptide receptor subtype VPAC2: role of basic residues in the second transmembrane helix. British Journal of Pharmacology. 133(8). 1249–1254. 15 indexed citations
8.
Vertongen, P., Rosa M. Solano, M. G. Juarranz, et al.. (2001). Proline residue 280 in the second extracellular loop (EC2) of the VPAC2 receptor is essential for the receptor structure. Peptides. 22(9). 1363–1370. 9 indexed citations
9.
Backer, Tine De, Marc De Buyzere, P. Vertongen, et al.. (2000). Extensive deep vein thrombosis in a young woman. Case report.. PubMed. 19(4). 369–72.
10.
Jordaens, Luc, Jan Trouerbach, René Tavernier, et al.. (1997). Conversion of atrial fibrillation to sinus rhythm and rate control by digoxin in comparison to placebo. European Heart Journal. 18(4). 643–648. 98 indexed citations
11.
Vertongen, P., J Fournet, Hélène Martelli, et al.. (1997). Comparison between vasoactive intestinal polypeptide and pituitary adenylate cyclase activating polypeptide levels in neuroblastoma tumour tissues. Neuropeptides. 31(5). 409–413. 14 indexed citations
12.
Vertongen, P., Mireille Delhase, Fabienne Rajas, et al.. (1996). Pituitary adenylate cyclase-activating polypeptide/vasoactive intestinal polypeptide receptor subtypes are differently expressed in rat transplanted pituitary tumours (SMtTW) and in the normal gland. Journal of Molecular Endocrinology. 16(3). 239–248. 8 indexed citations
13.
Vertongen, P., Isabelle Camby, Francis Darro, Róbert Kiss, & Patrick Robberecht. (1996). VIP and pituitary adenylate cyclase activating polypeptide (PACAP) have an antiproliferative effect on the T98G human glioblastoma cell line through interaction with VIP2 receptor. Neuropeptides. 30(5). 491–496. 45 indexed citations
14.
Laethem, Jean‐Luc Van, P. Vertongen, Jacques Devière, et al.. (1995). Detection of c-Ki-ras gene codon 12 mutations from pancreatic duct brushings in the diagnosis of pancreatic tumours.. Gut. 36(5). 781–787. 73 indexed citations
15.
Robberecht, Patrick, M.C. Woussen-Colle, P. Vertongen, et al.. (1994). Expression of pituitary adenylate cyclase activating polypeptide (PACAP) receptors in human glial cell tumors. Peptides. 15(4). 661–665. 31 indexed citations
16.
Svoboda, Michal, M. Tastenoy, P. Vertongen, & Patrick Robberecht. (1994). Relative quantitative analysis of glucagon receptor mRNA in rat tissues. Molecular and Cellular Endocrinology. 105(2). 131–137. 114 indexed citations
17.
18.
Robberecht, Patrick, P. Vertongen, B. Velkeniers, et al.. (1993). Receptors for pituitary adenylate cyclase activating peptides in human pituitary adenomas.. The Journal of Clinical Endocrinology & Metabolism. 77(5). 1235–1239. 38 indexed citations
19.
Vertongen, P., et al.. (1992). Ontogenic development of PACAP and PACAP receptors in rat brain. Regulatory Peptides. 40(2). 271–271. 1 indexed citations
20.
Duprez, Daniel, et al.. (1989). Circulatory changes in muscle and skin arteries in orthostatic hypotension and constitutional hypotension. Journal of Hypertension. 7(6). 86–87.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by S Ciani Breakdown of academic impact, for papers by Chiara Caliumi Breakdown of academic impact, for papers by O Kida Breakdown of academic impact, for papers by Masateru Nishiki Breakdown of academic impact, for papers by Hiroyuki Konya Breakdown of academic impact, for papers by Jean-Marie Gasc Breakdown of academic impact, for papers by Edit Gláz Breakdown of academic impact, for papers by Kazuwa Nakao Breakdown of academic impact, for papers by P Chowdhury Breakdown of academic impact, for papers by Kazuyoshi Tadokoro
Rankless by CCL
2026